---
figid: PMC9500434__fphar-13-960375-g008
figtitle: Fucoxanthin prevents breast cancer metastasis by interrupting circulating
  tumor cells adhesion and transendothelial migration
organisms:
- Armoracia rusticana
- Glycine max
- Phaeophyceae
- Saccharina japonica
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9500434
filename: fphar-13-960375-g008.jpg
figlink: /pmc/articles/PMC9500434/figure/F8/
number: F8
caption: Schematic diagram of the mechanism of Fx prevents breast cancer metastasis.
  On the one hand, Fx inhibits TNF-α-induced CAMs (ICAM-1, VCAM-1, and E-selectin)
  expression on endothelial cells by inhibiting the NF-кB signaling pathway, resulting
  in the interruption of CTCs adhesion to the vascular endothelium. On the other hand,
  Fx reduces EMT and cancer cell motility by regulating PI3K/AKT and FAK/Paxillin
  signaling pathways, resulting in the inhibition of cancer cell transendothelial
  migration. Furthermore, Fx enhances antitumor immune responses by substantially
  increasing the subsets of Tc cells in the peripheral immune system. These beneficial
  effects of Fx collectively resulted in the suppression of CTCs-induced cancer metastasis.
papertitle: Fucoxanthin prevents breast cancer metastasis by interrupting circulating
  tumor cells adhesion and transendothelial migration.
reftext: Weiyu Wang, et al. Front Pharmacol. 2022;13:960375.
year: '2022'
doi: 10.3389/fphar.2022.960375
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: 'fucoxanthin (CID: 5281239) | cancer metastasis chemoprevention | transendothelial
  migration | cell adhesion | epithelial-to-mesenchymal transition (EMT) | NF-κB signaling
  pathway | PI3K/Akt signaling pathway | FAK/Paxillin signaling pathway'
automl_pathway: 0.9577332
figid_alias: PMC9500434__F8
figtype: Figure
redirect_from: /figures/PMC9500434__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9500434__fphar-13-960375-g008.html
  '@type': Dataset
  description: Schematic diagram of the mechanism of Fx prevents breast cancer metastasis.
    On the one hand, Fx inhibits TNF-α-induced CAMs (ICAM-1, VCAM-1, and E-selectin)
    expression on endothelial cells by inhibiting the NF-кB signaling pathway, resulting
    in the interruption of CTCs adhesion to the vascular endothelium. On the other
    hand, Fx reduces EMT and cancer cell motility by regulating PI3K/AKT and FAK/Paxillin
    signaling pathways, resulting in the inhibition of cancer cell transendothelial
    migration. Furthermore, Fx enhances antitumor immune responses by substantially
    increasing the subsets of Tc cells in the peripheral immune system. These beneficial
    effects of Fx collectively resulted in the suppression of CTCs-induced cancer
    metastasis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHUK
  - NFKBIA
  - NFKB1
  - ICAM1
  - VCAM1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTK2
  - AKT1
  - AKT2
  - AKT3
  - CFL1
  - VPS72
  - ITK
  - SLC22A3
  - SNAI1
  - TWIST1
  - ZEB1
  - CDH2
  - CTNNB1
  - Chuk
  - Nfkb1
  - Icam1
  - Vcam1
  - Sele
  - Pik3r1
  - Ptk2
  - Akt1
  - Cfl1
  - Itk
  - Slc22a3
  - Snai1
  - Twist1
  - Zeb1
  - Cdh2
  - Ctnnb1
  - gdf5
  - vcam1b
  - sele
  - ptk2ab
  - cfl1
  - cfl1l
  - snai1a
  - zeb1b
  - cdh2
  - ctnnb1
---
